Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

4 days Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? Zacks

Here is how ANI Pharmaceuticals (ANIP) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.

Pharmaceuticals

  X     

2 days Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha

   X     

2 days Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks

   X     

3 days Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential Yahoo Finance

   X     

3 days Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness Seeking Alpha

   X     

4 days Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

4 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

4 days Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks

   X     

4 days Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

   X     

5 days Here’s Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock Zacks

   X     

5 days Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha

   X     

5 days Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ Yahoo Finance

   X     

5 days Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Yahoo Finance

   X     

5 days Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital Yahoo Finance

   X     

5 days Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring Seeking Alpha

   X     

6 days Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents Seeking Alpha

   X     

6 days Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock? Zacks

   X     

1 week Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market Yahoo Finance

   X     

1 week Telix Pharmaceuticals: Australian Company And A Solid Recent U.S. IPO Seeking Alpha

   X     

1 week All You Need to Know About ANI (ANIP) Rating Upgrade to Buy Zacks

   X     

1 week How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

   X     

1 week The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex Zacks

   X     

1 week The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks

   X     

2 weeks NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here’s Why Zacks

   X     

2 weeks Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha

   X     

2 weeks Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks

   X     

2 weeks Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

   X     

2 weeks Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

   X     

2 weeks Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist Yahoo Finance

   X     

2 weeks Anebulo Pharmaceuticals collaborates with FDA to advance selonabant Yahoo Finance

   X     

2 weeks Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

   X     

2 weeks Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

   X     

2 weeks Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

   X     

2 weeks Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

   X     

2 weeks Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

   X     

2 weeks Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

   X     

2 weeks Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

   X     

2 weeks Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

   X     

2 weeks Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

   X     

2 weeks Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

   X     

2 weeks Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

   X     

2 weeks VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

   X     

2 weeks Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

   X     

2 weeks Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

   X     

2 weeks Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

   X     

2 weeks Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

   X     

3 weeks Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

   X     

3 weeks REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

   X     

3 weeks Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

   X     

3 weeks Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

3 weeks SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News